4 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 4 of 4 clinical reviews.
Evidence-based review of empagliflozin (Jardiance) efficacy differences in South Asian populations, including pharmacogenomic factors, cardiovascular outcomes, and dosing considerations.
Evidence-based review of how empagliflozin safety, efficacy, and dosing considerations differ in South Asian populations, including pharmacogenomic factors, cardiovascular outcomes, and clinical monitoring guidance.
What is and is not established about empagliflozin (Jardiance) efficacy and safety in Black and African ancestry patients, with an evidence-boundary map for clinicians and patients pending qualified medical review.
A guide to empagliflozin (Jardiance) dosing, efficacy, and safety in Black and African ancestry patients, covering EMPA-REG OUTCOME subgroup data, G6PD prevalence, ACE inhibitor interactions, and CKD risk.